{"id":4503,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2019-07-25","marketCap":528.5099487304688,"name":"Health Catalyst Inc","phone":"18017086800","outstanding":60.470001220703125,"symbol":"HCAT","website":"https://www.healthcatalyst.com/","industry":"Health Care"},"price":8.6675,"year":2024,"month":9,"day":19,"weekday":"Thursday","title":"Impact of corporate earnings reports on Health Catalyst Inc stock's price movements","date":"2024-09-19","url":"/posts/2024/09/19/HCAT","content":[{"section":"Earnings Report 1","text":"Health Catalyst Inc released its Q1 2021 earnings report on April 27, 2021. The report revealed that the company's revenue increased by 31% compared to the same quarter in the previous year, reaching $66.9 million. Additionally, the net loss for the quarter was $0.16 per share, which was slightly lower than analysts' expectations. The positive revenue growth and better-than-expected net loss led to an initial surge in the stock price."},{"section":"Earnings Report 2","text":"On July 29, 2021, Health Catalyst Inc released its Q2 2021 earnings report. The report indicated a significant growth in revenue, with an increase of 32% compared to the same quarter in the previous year, amounting to $59.2 million. Additionally, the company reported a net loss of $0.15 per share, which was in line with analysts' estimates. Following the release of the report, the stock price experienced a moderate increase."},{"section":"Earnings Report 3","text":"The Q3 2021 earnings report for Health Catalyst Inc was released on November 3, 2021. The report outlined a substantial revenue growth of 31% compared to the same quarter in the previous year, amounting to $67.3 million. However, the company reported a higher-than-expected net loss of $0.23 per share. As a result, the stock price initially experienced a slight decline."},{"section":"Earnings Report 4","text":"Health Catalyst Inc released its Q4 2021 earnings report on February 23, 2022. The report demonstrated a remarkable revenue growth of 33% compared to the same quarter in the previous year, reaching $80.6 million. Moreover, the company reported a net loss of $0.11 per share, which was lower than analysts' expectations. This positive earnings report led to a significant surge in the stock price."},{"section":"Conclusion","text":"Based on the analysis of recent corporate earnings reports, it can be observed that positive revenue growth generally has a positive impact on the stock price of Health Catalyst Inc. However, instances of higher-than-expected net losses have shown a slight negative impact on the stock price. Overall, the market's reaction to the earnings reports suggests that investors value revenue growth more than the net loss figures in determining the stock's price movements."}],"tags":["CrossOver21","Long","Health Care"],"news":null}